Malignant neoplasm of unspecified site of left male breast
- C50.922 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C50.922 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C50.922 – other international versions of ICD-10 C50.922 may differ.
ICD-10-CM Coding Rules
- C50.922 is applicable to male patients.
The following code(s) above C50.922 contain annotation back-references
that may be applicable to C50.922:
Approximate Synonyms
- Cancer, male breast, left breast
- Male breast cancer, bilateral breasts
- Malignant phyllodes tumor of bilateral male breasts
- Malignant phyllodes tumor of left male breast
- Phyllodes tumor, malignant, male bilat breasts
- Phyllodes tumor, malignant, male left breast
- Primary malignant neoplasm of bilateral male breasts
- Primary malignant neoplasm of left male breast
- Recurrent male breast cancer, bilat breasts
- Recurrent male breast cancer, left breast
- Recurrent primary malignant neoplasm of bilateral male breasts
- Recurrent primary malignant neoplasm of left male breast
ICD-10-CM C50.922 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 582 Mastectomy for malignancy with cc/mcc
- 583 Mastectomy for malignancy without cc/mcc
- 597 Malignant breast disorders with mcc
- 598 Malignant breast disorders with cc
- 599 Malignant breast disorders without cc/mcc
Convert C50.922 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change